Synthesis and structure–activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARα selective activators- PPARα and PPARγ selectivity modulation

Xiang‐Yang Ye(Hangzhou Normal University), Joseph A. Tino(Institut des Maladies Métaboliques et Cardiovasculaires), Raijit Srivastava(Bristol-Myers Squibb (United States)), Denise Grimm(Louisville Metabolic and Atherosclerosis Research Center), Jonathan Lippy(Bristol-Myers Squibb (United States)), Peter T. W. Cheng(Bristol-Myers Squibb (United States)), Rongan Zhang(Bristol-Myers Squibb (United States)), Bowman Miao(Louisville Metabolic and Atherosclerosis Research Center), Lisa Zhang(The University of Sydney), Celeste Twamley(Bristol-Myers Squibb (United States)), Debra Search(Louisville Metabolic and Atherosclerosis Research Center), J.K. Muckelbauer(Institute of Crystallography), Vinayak Hosagrahara, Hossain Monshizadegan(Louisville Metabolic and Atherosclerosis Research Center), Kenneth T. Locke(Medicines Evaluation Unit), Hao Zhang(Bristol-Myers Squibb (United States)), Stephanie Chen(Rutgers, The State University of New Jersey), Litao Zhang(Tianjin University of Traditional Chinese Medicine), K O'Malley(Beaumont Hospital), ChiehYing Y. Chang(Institute of Crystallography), Ranjan Mukherjee, Tuo Yang(University of Pittsburgh), Daniel S. Meyers(Louisville Metabolic and Atherosclerosis Research Center), Yongmi An(Protein Express (United States))
Bioorganic & Medicinal Chemistry Letters
March 9, 2010
Cited by 10


Related Papers